Streetbeat News

Products Services

ANNX

Annexon presented results from its completed Phase 3 trial of ANX005, a C1q-targeted immunotherapy for Guillain-Barré Syndrome (GBS). The trial showed a highly statistically significant effect on the primary endpoint, with early, robust, and durable treatment effects. The single-dose administration was well-tolerated with mostly mild to moderate adverse events.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 9:02 pm

LHX

MMM

Josh Brown of Ritholtz Wealth Management is highly optimistic about 3M Company (NYSE: MMM), citing a promising technical setup and recent positive developments, including a new CEO and a healthcare business spin-off. He anticipates a breakout if the stock surpasses the $105 to $108 range. Stephanie Link of Hightower Advisors also supports this view, highlighting the new CEO's successful track record at L3Harris Technologies Inc (NYSE: LHX).

Portfolio Pulse from Adam Eckert

June 25, 2024 | 8:59 pm

DKNG

PENN

Dave Portnoy, founder of Barstool Sports, lost a $150,000 bet on the Edmonton Oilers but is trying to win back $1.2 million with a $200,000 bet on the Philadelphia Phillies to win the 2024 World Series. He placed the bet through DraftKings. Barstool Sports, previously owned by Penn Entertainment, is now back with Portnoy.

Portfolio Pulse from Aaron Bry

June 25, 2024 | 8:54 pm

DJT

DKNG

Trump Media & Technology Group (NASDAQ:DJT) could see high volatility following the first 2024 presidential debate. The company's stock has experienced significant price swings related to events surrounding Donald Trump, including his legal troubles and election-related news. Sportsbook DraftKings Inc (NASDAQ:DKNG) is also offering a prediction pool for the debate.

Portfolio Pulse from Chris Katje

June 25, 2024 | 8:45 pm

SNAP

Snap Inc. (NYSE:SNAP) shares rose after the company announced new features to protect users from scammers, including expanded in-app warnings and enhanced friending protections. The stock is trading above its 50-day and 200-day moving averages, indicating a bullish trend.

Portfolio Pulse from Erica Kollmann

June 25, 2024 | 8:37 pm

ARGX

argenx presented new data from its autoimmune pipeline at the 2024 Peripheral Nerve Society Annual Meeting. The ARDA study data showed potential for empasiprubart to drive functional improvement and reduce relapse risk for MMN patients. The ADHERE+ data demonstrated the durability of functional improvements with VYVGART® Hytrulo, which is FDA approved for CIDP.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 8:32 pm

GM

GM's autonomous vehicle subsidiary, Cruise, has appointed Marc Whitten as its new CEO, effective July 16.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 8:32 pm

ALLK

Allakos shares are trading lower following the announcement of results from the Phase 1 study of intravenous AK006 in healthy volunteers.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 8:30 pm

NNE

Nano Nuclear Energy Inc. (NASDAQ:NNE) shares surged significantly after Benchmark raised its price target from $15 to $39. The stock's rise is driven by the U.S. Senate's approval of the ADVANCE Act and the company's acquisition of ALIP IP, enhancing its technological capabilities. NNE shares closed up 39.43% at $29.10.

Portfolio Pulse from Vaishali Prayag

June 25, 2024 | 8:24 pm

ACIC

SBCF

SNV

American Coastal Insurance has extended its exclusive managing agency contract with AmRisc for five years, effective June 1, 2024, and expiring January 1, 2029. The contract remains exclusive for the Florida admitted condominium association property insurance market.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 8:17 pm